Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuron (IMRN) Cash & Equivalents (2017 - 2025)

Immuron has reported Cash & Equivalents over the past 9 years, most recently at $1.8 million for Q2 2025.

  • Quarterly results put Cash & Equivalents at $1.8 million for Q2 2025, down 76.4% from a year ago — trailing twelve months through Jun 2025 was $1.8 million (down 76.4% YoY), and the annual figure for FY2025 was $1.8 million, down 76.0%.
  • Cash & Equivalents for Q2 2025 was $1.8 million at Immuron, down from $7.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for IMRN hit a ceiling of $19.3 million in Q2 2021 and a floor of $1.8 million in Q2 2025.
  • Median Cash & Equivalents over the past 5 years was $11.5 million (2023), compared with a mean of $11.2 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 805.35% in 2021 and later plummeted 76.4% in 2025.
  • Immuron's Cash & Equivalents stood at $19.3 million in 2021, then dropped by 17.89% to $15.8 million in 2022, then dropped by 27.58% to $11.5 million in 2023, then crashed by 33.01% to $7.7 million in 2024, then plummeted by 76.4% to $1.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $1.8 million (Q2 2025), $7.7 million (Q2 2024), and $11.5 million (Q2 2023) per Business Quant data.